Novel approach to creating sustainable packaging from rice husks
Researchers have created a new approach to the designing of eco-friendly nanofibres extracted from rice husks, addressing the critical need for sustainable packaging materials in food and biopharmaceutical products.
A team of researchers, led by YoungHoon Jung and HyeJee Kang from Kyungpook National University, have demonstrated a novel method of creating chitosan-based composite films utilising nanofibres extracted from rice husks. The method highlighted in their research is notable for its usage of an agricultural waste product in the production of a potential packaging material, promoting circular economic practices.
The process involves a chemical pretreatment of rice husks and enzymatic hydrolysis during a biorefinery process. This produces lignin-rich lignocellulose nanofibres. These nanofibres offer unique hydrophobic properties and strength. When incorporated into chitosan and formed into composite films, the material gives enhanced mechanical and structural integrity. By repurposing what would be a waste product, this process contributes to overall waste reduction and marks a step forward for sustainable resource management. Moreover, the controllable process developed by the researchers may also allow for customised film formation, increasing economic feasibility for the biomaterials industry.
Establishing a circular economy within the pharmaceutical supply chain has dominated talks around sustainability, with particular attention towards pharmaceutical packaging. The need for sustainable primary and secondary pharmaceutical packaging often present challenges related to scaling supply chain operations and safety and efficacy preservation of the drug products. This process demonstrates an innovative approach towards sustainable material development in tandem with the feasibility of creating composite films from waste products. For the pharmaceutical packaging sector, these composite films also offer unique UV-blocking properties, highlighting potential usage in pharmaceutical and biomedical device packaging. The lead researchers emphasised the significance of the study and innovative development method in paving the way forward for greener biomaterial packaging for food and pharma.
Sources:
1. Rice husk can be used as a promising sustainable packaging material [Accessed March 27, 2024] https://www.eurekalert.org/news-releases/1039048
2. Kang HJ, Lee YJ, Lee JK et al. Production of Chitosan-Based Composite Film Reinforced with Lignin-Rich Lignocellulose Nanofibres from Rice Husk, J. Bioresour. Bioprod. Published online 15 March 2024. doi: 10.1016/j.jobab.2024.03.002
3. The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner [Accessed March 27, 2024] https://www.cphi-online.com/the-cpo-starter-pack-why-and-when-to-bring-in-a-news120889.html
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Biogen acquires Apellis Pharmaceuticals to boost immunology and rare disease profile
Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas... -
News Gilead Sciences acquires Ouro Medicines for over US$2 billion
Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases.
-
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Dr Reddy's to launch generic semaglutide in India
Dr Reddy’s Laboratories, one of India’s leading pharmaceutical companies, is preparing to launch a generic version of semaglutide, branded as Obeda, in March. Obeda is expected to provide a more affordable alternative to Ozempic a... -
News Frontier Biotech and GSK Forge RNA Therapy Partnership
Frontier Biotechnologies and GSK have entered a global licensing agreement to advance small interfering RNA (siRNA) therapeutics. This collaboration grants GSK exclusive rights to develop and commercialise two promising siRNA candidates, marking a mile...